HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin-Lin Ma Selected Research

YZH-106

1/2016Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin-Lin Ma Research Topics

Disease

3Infections
01/2019 - 11/2014
3Human Influenza (Influenza)
01/2016 - 03/2013
2Carcinogenesis
01/2021 - 10/2020
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 10/2020
2Neoplasms (Cancer)
01/2021 - 10/2020
2Hypertension (High Blood Pressure)
01/2020 - 02/2011
1Renal Insufficiency (Renal Failure)
01/2020
1Acute Coronary Syndrome
01/2020
1Spinal Cord Injuries (Spinal Cord Injury)
03/2019
1Inflammation (Inflammations)
10/2018
1Diabetes Mellitus
10/2018
1Vascular System Injuries
10/2018
1Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1Ischemia
01/2017
1Cognitive Dysfunction
01/2017
1Reperfusion Injury
01/2017
1Birth Weight (Birth Weights)
11/2016
1Premature Birth (Birth, Premature)
11/2016
1Diabetes Complications
10/2016
1Cardiovascular Diseases (Cardiovascular Disease)
10/2016
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2016
1Wounds and Injuries (Trauma)
10/2016
1Body Weight (Weight, Body)
01/2016
1Communicable Diseases (Infectious Diseases)
01/2016
1Opioid-Related Disorders (Opiate Addiction)
12/2014
1Paramyxoviridae Infections (Parainfluenza)
11/2014
1Chronic Renal Insufficiency
08/2013
1Ulcer
02/2011
1Coronary Disease (Coronary Heart Disease)
02/2011
1Peptic Ulcer (Peptic Ulcers)
02/2011
1Pain (Aches)
02/2011
1Anemia
02/2011
1Hemorrhage
02/2011

Drug/Important Bio-Agent (IBA)

3Antiviral Agents (Antivirals)IBA
01/2019 - 12/2014
2erastinIBA
01/2021 - 10/2020
2MicroRNAs (MicroRNA)IBA
01/2021 - 10/2020
2Blood Glucose (Blood Sugar)IBA
01/2020 - 10/2018
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2017 - 10/2016
1CXCR4 Receptors (CXCR4 Receptor)IBA
03/2019
1Chemokine CXCL12IBA
03/2019
1Oxygen (Dioxygen)IBA
03/2019
1protoporphyrin IXIBA
01/2019
1ChloridesIBA
01/2019
1C-Reactive ProteinIBA
10/2018
1CreatinineIBA
10/2018
1InterleukinsIBA
10/2018
1NitrogenIBA
10/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018
1Urea (Carbamide)FDA LinkGeneric
10/2018
1CytokinesIBA
10/2018
1beta 2-Glycoprotein I (Apolipoprotein H)IBA
10/2018
1NAD (NADH)IBA
01/2018
1Calcium Channels (Calcium Channel)IBA
01/2018
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1ProgesteroneFDA LinkGeneric
11/2016
1NF-E2-Related Factor 2IBA
10/2016
1salvianolic acid AIBA
10/2016
1Streptozocin (Streptozotocin)FDA Link
10/2016
1AMP-Activated Protein KinasesIBA
10/2016
1PolyphenolsIBA
10/2016
1VaccinesIBA
01/2016
1YZH-106IBA
01/2016
1Pharmaceutical PreparationsIBA
12/2014
1Buprenorphine (Subutex)FDA LinkGeneric
12/2014
1Interferon-alpha (Interferon Alfa)IBA
11/2014
1Tryptophan-tRNA LigaseIBA
08/2013
1GlycosidesIBA
03/2013
1Oseltamivir (Tamiflu)FDA Link
03/2013
1gastrodinIBA
03/2013
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2011

Therapy/Procedure

1Cervical Cerclage
11/2016
1Therapeutics
01/2016
1Oral Administration
03/2013